Suppr超能文献

奥马环素

Omadacycline.

作者信息

Baker Danial E

机构信息

Washington State University, Spokane, WA, USA.

出版信息

Hosp Pharm. 2019 Apr;54(2):80-87. doi: 10.1177/0018578718823730. Epub 2019 Jan 22.

DOI:10.1177/0018578718823730
PMID:30923399
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6431718/
Abstract

Each month, subscribers to receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation of publishes selected reviews in this column. For more information about , contact Wolters Kluwer customer service at 866-397-3433.

摘要

每月，订阅者会收到5至6篇关于新发布或处于3期临床试验后期阶段药物的有充分文献依据的专题论文。这些专题论文面向药学与治疗学委员会。订阅者还会每月收到关于对议程以及药学/护理在职培训有用药物的1页摘要专题论文。每月还会提供一份全面的目标药物利用评估/药物使用评估（DUE/MUE）。订阅后，专题论文可供订阅者在线获取。专题论文可进行定制以满足机构需求。通过合作，出版商在本专栏发表精选评论。如需了解更多关于……的信息，请致电866 - 397 - 3433联系威科集团客服。

相似文献

1
Omadacycline.奥马环素
Hosp Pharm. 2019 Apr;54(2):80-87. doi: 10.1177/0018578718823730. Epub 2019 Jan 22.
2
Formulary Drug Review: Betrixaban.处方药物审查：贝曲西班
Hosp Pharm. 2018 Feb;53(1):29-37. doi: 10.1177/0018578717739397. Epub 2017 Nov 6.
3
Formulary Drug Review: Edaravone.处方药物审查：依达拉奉
Hosp Pharm. 2017 Dec;52(11):732-736. doi: 10.1177/0018578717734877. Epub 2017 Oct 9.
4
Formulary Drug Review: Ocrelizumab.处方药物评审：奥瑞珠单抗
Hosp Pharm. 2017 Oct;52(9):599-606. doi: 10.1177/0018578717731733. Epub 2017 Sep 17.
5
Baloxavir Marboxil.巴洛沙韦酯
Hosp Pharm. 2019 Jun;54(3):165-169. doi: 10.1177/0018578719841044. Epub 2019 Apr 1.
6
Maribavir.马里巴韦
Hosp Pharm. 2023 Aug;58(4):336-344. doi: 10.1177/00185787221101480. Epub 2022 Dec 21.
7
Formulary Drug Review: Sufentanil Sublingual.处方药物评审：舒芬太尼舌下给药制剂
Hosp Pharm. 2019 Aug;54(4):222-228. doi: 10.1177/0018578719851726. Epub 2019 May 29.
8
Angiotensin II.血管紧张素II
Hosp Pharm. 2018 Jul;53(4):230-233. doi: 10.1177/0018578718778224. Epub 2018 May 24.
9
Lefamulin.来法莫林
Hosp Pharm. 2022 Dec;57(6):704-711. doi: 10.1177/0018578719897071. Epub 2020 Jan 2.
10
Sodium Zirconium Cyclosilicate.环硅酸锆钠
Hosp Pharm. 2019 Feb;54(1):12-19. doi: 10.1177/0018578718817470. Epub 2018 Dec 14.

引用本文的文献

1
Investigational and Experimental Drugs for Community-Acquired Pneumonia: the Current Evidence.用于社区获得性肺炎的研究性和实验性药物：当前证据
J Exp Pharmacol. 2020 Nov 19;12:529-538. doi: 10.2147/JEP.S259286. eCollection 2020.

本文引用的文献

1
Activity of omadacycline tested against Enterobacteriaceae causing urinary tract infections from a global surveillance program (2014).来自一项全球监测项目（2014年）的对引起尿路感染的肠杆菌科细菌进行测试的奥玛环素活性
Diagn Microbiol Infect Dis. 2018 Jun;91(2):179-183. doi: 10.1016/j.diagmicrobio.2018.01.019. Epub 2018 Feb 24.
2
Activities of Omadacycline and Comparators against Anaerobic Bacteria.奥马环素及对照药物对厌氧菌的活性。
Antimicrob Agents Chemother. 2018 Mar 27;62(4). doi: 10.1128/AAC.00047-18. Print 2018 Apr.
3
Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe as Part of the 2016 SENTRY Antimicrobial Surveillance Program.作为 2016 年 SENTRY 抗菌药物监测计划的一部分，对来自美国和欧洲的临床分离株进行了奥马环素活性测试的监测。
Antimicrob Agents Chemother. 2018 Mar 27;62(4). doi: 10.1128/AAC.02327-17. Print 2018 Apr.
4
The role of omadacycline in skin and soft tissue infections.奥马环素在皮肤和软组织感染中的作用。
Curr Opin Infect Dis. 2018 Apr;31(2):148-154. doi: 10.1097/QCO.0000000000000429.
5
Safety and Pharmacokinetics of the Aminomethylcycline Antibiotic Omadacycline Administered to Healthy Subjects in Oral Multiple-Dose Regimens.口服多次给药方案中健康受试者应用氨甲基环素类抗生素奥马环素的安全性和药代动力学。
Antimicrob Agents Chemother. 2018 Jan 25;62(2). doi: 10.1128/AAC.01487-17. Print 2018 Feb.
6
Pharmacokinetics and Safety of Omadacycline in Subjects with Impaired Renal Function.奥马环素在肾功能损害受试者中的药代动力学和安全性。
Antimicrob Agents Chemother. 2018 Jan 25;62(2). doi: 10.1128/AAC.02057-17. Print 2018 Feb.
7
Activity of omadacycline tested against Streptococcus pneumoniae from a global surveillance program (2014).2014年全球监测项目中奥马环素对肺炎链球菌的活性检测
Diagn Microbiol Infect Dis. 2018 Feb;90(2):143-147. doi: 10.1016/j.diagmicrobio.2017.10.010. Epub 2017 Oct 19.
8
Comparison of Omadacycline and Tigecycline Pharmacokinetics in the Plasma, Epithelial Lining Fluid, and Alveolar Cells of Healthy Adult Subjects.比较奥马环素和替加环素在健康成年受试者血浆、上皮衬液和肺泡细胞中的药代动力学。
Antimicrob Agents Chemother. 2017 Aug 24;61(9). doi: 10.1128/AAC.01135-17. Print 2017 Sep.
9
Surveillance of Omadacycline Activity against Clinical Isolates from a Global Collection (North America, Europe, Latin America, Asia-Western Pacific), 2010-2011.2010 - 2011年对来自全球范围（北美、欧洲、拉丁美洲、亚洲 - 西太平洋）的临床分离株进行的奥玛环素活性监测。
Antimicrob Agents Chemother. 2017 Apr 24;61(5). doi: 10.1128/AAC.00018-17. Print 2017 May.
10
and Activity of Omadacycline against Two Biothreat Pathogens, Bacillus anthracis and Yersinia pestis.奥马环素对两种生物威胁病原体炭疽芽孢杆菌和鼠疫耶尔森菌的活性。
Antimicrob Agents Chemother. 2017 Apr 24;61(5). doi: 10.1128/AAC.02434-16. Print 2017 May.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验